Literature DB >> 7044350

The production of bacteriocin-like substances by the oral bacterium Streptococcus salivarius.

R P Dempster, J R Tagg.   

Abstract

Inhibitory substances produced by six strains of Streptococcus salivarius were isolated and partially characterized. The six prototype producer strains were selected initially on the basis of their differing spectra of inhibitory activity when tested against a set of nine standard indicator strains. Optimal production conditions were defined for each producer strain and inhibitor-containing extracts were obtained for characterization studies. All of the inhibitors appeared to be proteinaceous substances of molecular weight greater than 3500. When tested against a Streptococcus pyogenes indicator strain, one of the inhibitors was bactericidal, but the other five appeared to be bacteriostatic. Some differences between the inhibitors were observed with respect to heat and enzyme sensitivities.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7044350     DOI: 10.1016/0003-9969(82)90136-4

Source DB:  PubMed          Journal:  Arch Oral Biol        ISSN: 0003-9969            Impact factor:   2.633


  12 in total

1.  A new alkaline pH-adjusted medium enhances detection of beta-hemolytic streptococci by minimizing bacterial interference due to Streptococcus salivarius.

Authors:  K P Dierksen; N L Ragland; J R Tagg
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

2.  Using oral microbial DNA analysis to identify expirated bloodspatter.

Authors:  Andrea E Donaldson; Michael C Taylor; Stephen J Cordiner; Iain L Lamont
Journal:  Int J Legal Med       Date:  2010-02-17       Impact factor: 2.686

Review 3.  Novel lantibiotics and their pre-peptides.

Authors:  I F Nes; J R Tagg
Journal:  Antonie Van Leeuwenhoek       Date:  1996-02       Impact factor: 2.271

4.  Salivaricin A2 and the novel lantibiotic salivaricin B are encoded at adjacent loci on a 190-kilobase transmissible megaplasmid in the oral probiotic strain Streptococcus salivarius K12.

Authors:  Otto Hyink; Philip A Wescombe; Mathew Upton; Nancy Ragland; Jeremy P Burton; John R Tagg
Journal:  Appl Environ Microbiol       Date:  2006-12-28       Impact factor: 4.792

5.  Something Old and Something New: An Update on the Amazing Repertoire of Bacteriocins Produced by Streptococcus salivarius.

Authors:  Philip A Wescombe; Nicholas C K Heng; Jeremy P Burton; John R Tagg
Journal:  Probiotics Antimicrob Proteins       Date:  2010-03       Impact factor: 4.609

6.  Inhibition of propionibacterium acnes by bacteriocin-like inhibitory substances (BLIS) produced by Streptococcus salivarius.

Authors:  Whitney P Bowe; Jennifer C Filip; Joseph M DiRienzo; Alla Volgina; David J Margolis
Journal:  J Drugs Dermatol       Date:  2006-10       Impact factor: 2.114

7.  Inhibitory substances produced by Streptococcus salivarius and colonization of the upper respiratory tract with group A streptococci.

Authors:  W C Huskins; E L Kaplan
Journal:  Epidemiol Infect       Date:  1989-06       Impact factor: 2.451

8.  Isolation and characterization of the lantibiotic salivaricin A and its structural gene salA from Streptococcus salivarius 20P3.

Authors:  K F Ross; C W Ronson; J R Tagg
Journal:  Appl Environ Microbiol       Date:  1993-07       Impact factor: 4.792

9.  Production of the lantibiotic salivaricin A and its variants by oral streptococci and use of a specific induction assay to detect their presence in human saliva.

Authors:  Philip A Wescombe; Mathew Upton; Karen P Dierksen; Nancy L Ragland; Senthuran Sivabalan; Ruth E Wirawan; Megan A Inglis; Chris J Moore; Glenn V Walker; Chris N Chilcott; Howard F Jenkinson; John R Tagg
Journal:  Appl Environ Microbiol       Date:  2006-02       Impact factor: 4.792

10.  Salivaricin G32, a Homolog of the Prototype Streptococcus pyogenes Nisin-Like Lantibiotic SA-FF22, Produced by the Commensal Species Streptococcus salivarius.

Authors:  Philip A Wescombe; Kristin H Dyet; Karen P Dierksen; Daniel A Power; Ralph W Jack; Jeremy P Burton; Megan A Inglis; Anna L Wescombe; John R Tagg
Journal:  Int J Microbiol       Date:  2012-04-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.